Arkolith/Insider Trading/PBYI/Form 4

Stuglik Brian M

DirectorPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jun 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$58K
Net Open-Market Flow
-$58K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2026Sell(S)8K$7.20$58K114K
Jun 11, 2026Grant(A)27K—$0122K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-020708) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML